120 related articles for article (PubMed ID: 12711447)
1. Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion.
De Brabander C; Vervaet C; Remon JP
J Control Release; 2003 Apr; 89(2):235-47. PubMed ID: 12711447
[TBL] [Abstract][Full Text] [Related]
2. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation.
Verhoeven E; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2006 Jul; 63(3):320-30. PubMed ID: 16517135
[TBL] [Abstract][Full Text] [Related]
3. Influence of formulation and process parameters on the release characteristics of ethylcellulose sustained-release mini-matrices produced by hot-melt extrusion.
Verhoeven E; De Beer TR; Van den Mooter G; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2008 May; 69(1):312-9. PubMed ID: 18036793
[TBL] [Abstract][Full Text] [Related]
4. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
[TBL] [Abstract][Full Text] [Related]
5. Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release.
Lopes CM; Sousa Lobo JM; Costa P; Pinto JF
Drug Dev Ind Pharm; 2006 Jan; 32(1):95-106. PubMed ID: 16455608
[TBL] [Abstract][Full Text] [Related]
6. A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices.
Verstraete G; Mertens P; Grymonpré W; Van Bockstal PJ; De Beer T; Boone MN; Van Hoorebeke L; Remon JP; Vervaet C
Int J Pharm; 2016 Nov; 513(1-2):602-611. PubMed ID: 27686052
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of ibuprofen from hot-melt extruded mini-matrices.
De Brabander C; Vervaet C; Van Bortel L; Remon JP
Int J Pharm; 2004 Mar; 271(1-2):77-84. PubMed ID: 15129975
[TBL] [Abstract][Full Text] [Related]
8. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer.
Ochoa L; Igartua M; Hernández RM; Gascón AR; Pedraz JL
J Pharm Pharm Sci; 2005 Jun; 8(2):132-40. PubMed ID: 16124924
[TBL] [Abstract][Full Text] [Related]
9. PVP VA64 as a novel release-modifier for sustained-release mini-matrices prepared via hot melt extrusion.
Li Y; Lu M; Wu C
Drug Deliv Transl Res; 2018 Dec; 8(6):1670-1678. PubMed ID: 29127610
[TBL] [Abstract][Full Text] [Related]
10. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
Hiremath PS; Saha RN
Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation.
Quinten T; De Beer T; Onofre FO; Mendez-Montealvo G; Wang YJ; Remon JP; Vervaet C
J Pharm Sci; 2011 Jul; 100(7):2858-70. PubMed ID: 21254067
[TBL] [Abstract][Full Text] [Related]
12. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
Nokhodchi A; Hassan-Zadeh D; Monajjem-Zadeh F; Taghi-Zadeh N
Acta Pharm; 2008 Jun; 58(2):151-62. PubMed ID: 18515225
[TBL] [Abstract][Full Text] [Related]
13. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
[TBL] [Abstract][Full Text] [Related]
14. Novel Hot Melt Extruded Matrices of Hydroxypropyl Cellulose and Amorphous Felodipine-Plasticized Hydroxypropyl Methylcellulose as Controlled Release Systems.
Yi S; Wang J; Lu Y; Ma R; Gao Q; Liu S; Xiong S
AAPS PharmSciTech; 2019 Jun; 20(6):219. PubMed ID: 31201583
[TBL] [Abstract][Full Text] [Related]
15. Continuous production of controlled release dosage forms based on hot-melt extruded gum arabic: Formulation development, in vitro characterization and evaluation of potential application fields.
Kipping T; Rein H
Int J Pharm; 2016 Jan; 497(1-2):36-53. PubMed ID: 26617317
[TBL] [Abstract][Full Text] [Related]
16. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Verstraete G; Van Renterghem J; Van Bockstal PJ; Kasmi S; De Geest BG; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2016 Jun; 506(1-2):214-21. PubMed ID: 27113866
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
Quinten T; De Beer T; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
[TBL] [Abstract][Full Text] [Related]
18. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
Patil H; Tiwari RV; Upadhye SB; Vladyka RS; Repka MA
Int J Pharm; 2015 Dec; 496(1):33-41. PubMed ID: 25863118
[TBL] [Abstract][Full Text] [Related]
19. Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
Chandran S; Ravi P; Saha RN
Yakugaku Zasshi; 2006 Jul; 126(7):505-14. PubMed ID: 16819273
[TBL] [Abstract][Full Text] [Related]
20. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
